Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528418 | Clinical Therapeutics | 2017 | 29 Pages |
Abstract
The results suggest that the main factors driving treatment choice at any stage of intensification were age, hemoglobin A1c, BMI, renal and cardiac morbidity, and treatment history. These drivers were consistent with guidelines on, and contraindications of, specific medications. Differences between countries were generally consistent with, but not solely attributable to, differences in local guidelines and reimbursement policies.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Edith M. PhD, Jetty A. MSc, Gillian C. PhD, Daniel PhD, Francesco PhD, Niklas PhD, Irene D. PhD,